oxprenolol has been researched along with Arrhythmia in 40 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 9.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "In 736 patients, 24 hour electrocardiographic recordings were performed 14 to 36 days after acute myocardial infarction before the start of randomized treatment with 320 mg of slow release oxprenolol (n = 358) or placebo (n = 378)." | 9.05 | Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1985) |
| "Authors have analyzed the antiarrhythmic effect of oxprenolol, a beta blocking agent, in the treatment of various types of arrhythmias and in the prophylaxis of recurrences of auricular flutter and fibrillation." | 9.04 | [Oxprenolol in the treatment and prevention of cardiac arrhythmias]. ( Camerini, F; Crepaldi, L; Martinoli, E; Medugno, G; Scardi, S, 1975) |
| "The role of the cardiac beta receptor in the genesis and perpetuation of ouabain-induced ventricular tachyarrhythmias (VT) was investigated in the chloralose (20 mg/kg)-urethane (200 mg/kg) anesthetized dog." | 7.65 | Effect of beta receptor blockade on the initiation and perpetuation of ouabain-induced ventricular tachyarrhythmia. ( Apantaku, FO; Baumgarten, CM; Ten Eick, RE, 1975) |
| "Oxprenolol, a new beta-receptor blocking drug with intrinsic sympathomimetic activity, was used to treat 63 episodes of cardiac arrhythmia occurring in 43 patients with acute myocardial infarction or myocardial ischaemia." | 7.65 | Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. ( Pistevos, AC; Sandler, G, 1971) |
| "Then experimental arrhythmias were induced by methacholine or adrenaline (Adr) on RWIS mice, and their frequencies of appearance were examined." | 5.27 | [Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "Oxprenolol and carteolol were observed to have mild effects on the abnormal ECG as compared with propranolol." | 5.27 | [The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "As for two-stage coronary ligation arrhythmia, oxprenolol suppressed only that observed 48 hours after coronary ligation using higher doses (5 to 10 mg/kg)." | 5.26 | Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs. ( Hashimoto, K; Imai, S; Matsubara, I; Matsuda, H; Tsukada, T, 1978) |
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 5.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "In 736 patients, 24 hour electrocardiographic recordings were performed 14 to 36 days after acute myocardial infarction before the start of randomized treatment with 320 mg of slow release oxprenolol (n = 358) or placebo (n = 378)." | 5.05 | Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1985) |
| "Authors have analyzed the antiarrhythmic effect of oxprenolol, a beta blocking agent, in the treatment of various types of arrhythmias and in the prophylaxis of recurrences of auricular flutter and fibrillation." | 5.04 | [Oxprenolol in the treatment and prevention of cardiac arrhythmias]. ( Camerini, F; Crepaldi, L; Martinoli, E; Medugno, G; Scardi, S, 1975) |
| " Oxprenolol was the most potent antagonist of the isoprenaline induced cardiac arrhythmias." | 3.65 | Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits. ( Darabi, MK; Hague, MA; Khalighi, MR, 1977) |
| "The role of the cardiac beta receptor in the genesis and perpetuation of ouabain-induced ventricular tachyarrhythmias (VT) was investigated in the chloralose (20 mg/kg)-urethane (200 mg/kg) anesthetized dog." | 3.65 | Effect of beta receptor blockade on the initiation and perpetuation of ouabain-induced ventricular tachyarrhythmia. ( Apantaku, FO; Baumgarten, CM; Ten Eick, RE, 1975) |
| "Oxprenolol, a new beta-receptor blocking drug with intrinsic sympathomimetic activity, was used to treat 63 episodes of cardiac arrhythmia occurring in 43 patients with acute myocardial infarction or myocardial ischaemia." | 3.65 | Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. ( Pistevos, AC; Sandler, G, 1971) |
| "Oxprenolol is a potent noncardioselective beta-adrenoceptor blocking drug with partial agonist activity of proved efficacy and high tolerability in patients at risk of various cardiovascular disease syndromes." | 2.36 | Oxprenolol in clinical practice. ( Taylor, SH, 1983) |
| "Consecutive arrhythmias (ventricular pairs and runs of ventricular premature beats) and left-ventricular dysfunction alone were associated with a low mortality of 4." | 1.28 | Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1990) |
| "Then experimental arrhythmias were induced by methacholine or adrenaline (Adr) on RWIS mice, and their frequencies of appearance were examined." | 1.27 | [Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "Oxprenolol and carteolol were observed to have mild effects on the abnormal ECG as compared with propranolol." | 1.27 | [The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "As for two-stage coronary ligation arrhythmia, oxprenolol suppressed only that observed 48 hours after coronary ligation using higher doses (5 to 10 mg/kg)." | 1.26 | Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs. ( Hashimoto, K; Imai, S; Matsubara, I; Matsuda, H; Tsukada, T, 1978) |
| "Oxprenolol or pindolol were used as primary drugs in 8 cases." | 1.26 | [Therapy of postoperative arrhythmias (author's transl)]. ( Vormittag, E, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (97.50) | 18.7374 |
| 1990's | 1 (2.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilcox, RG | 1 |
| Rowley, JM | 1 |
| Hampton, JR | 1 |
| Mitchell, JR | 1 |
| Roland, JM | 1 |
| Banks, DC | 1 |
| Frishman, WH | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Krämer, B | 1 |
| Kübler, W | 1 |
| Kita, T | 2 |
| Hata, T | 2 |
| Harada, N | 2 |
| Itoh, E | 2 |
| Taylor, SH | 1 |
| Shanks, RG | 1 |
| Hague, MA | 1 |
| Darabi, MK | 1 |
| Khalighi, MR | 1 |
| Szegl, J | 1 |
| Szabó, J | 1 |
| Szentmiklósi, J | 1 |
| Harsányi, K | 1 |
| Korbonits, D | 1 |
| Lüderitz, B | 1 |
| Hashimoto, K | 1 |
| Tsukada, T | 1 |
| Matsuda, H | 1 |
| Matsubara, I | 1 |
| Imai, S | 1 |
| Martinoli, E | 1 |
| Medugno, G | 1 |
| Crepaldi, L | 1 |
| Scardi, S | 1 |
| Camerini, F | 1 |
| Vormittag, E | 1 |
| Apantaku, FO | 1 |
| Baumgarten, CM | 1 |
| Ten Eick, RE | 1 |
| Frisch, P | 1 |
| Contino, A | 1 |
| Elliott, HL | 1 |
| Campbell, BC | 1 |
| Morgan, I | 1 |
| Pongiglione, R | 1 |
| Ruffa, G | 1 |
| Di Biase, M | 1 |
| Guglielmi, R | 1 |
| Scarcia, A | 1 |
| Chiddo, A | 1 |
| Rizzon, P | 1 |
| Dubova, MN | 1 |
| Zisel'man, SB | 1 |
| Pankratov, AB | 1 |
| Crook, BR | 1 |
| Cashman, PM | 1 |
| Sukenik, S | 1 |
| Cristal, N | 1 |
| Miyazaki, M | 1 |
| Nioka, S | 1 |
| Fujita, T | 1 |
| Brooks, NH | 1 |
| Andresen, D | 2 |
| Bethge, KP | 2 |
| Boissel, JP | 2 |
| von Leitner, ER | 2 |
| Peyrieux, JC | 2 |
| Schröder, R | 3 |
| Tietze, U | 2 |
| Zamotaev, IP | 2 |
| Lozinskiĭ, LG | 2 |
| Sandomirskiĭ, BL | 2 |
| Gross, F | 1 |
| Lawrence, T | 1 |
| Frankl, WS | 1 |
| Votchal, BE | 1 |
| Vorob'eva, ZV | 1 |
| Gettes, LS | 1 |
| Singh, BN | 2 |
| Offerhaus, L | 1 |
| Jewitt, DE | 1 |
| Goch, JH | 1 |
| Fomina, AA | 1 |
| Spivak, AM | 1 |
| Mironova, KA | 1 |
| Reingardt, BK | 1 |
| Myburgh, DP | 1 |
| Broustet, P | 1 |
| Lacut, JY | 1 |
| Sandler, G | 1 |
| Pistevos, AC | 1 |
8 reviews available for oxprenolol and Arrhythmia
| Article | Year |
|---|---|
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Death | 1984 |
Oxprenolol in clinical practice.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Heart Rate; Humans; Hyperte | 1983 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias | 1973 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillatio | 1970 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
7 trials available for oxprenolol and Arrhythmia
| Article | Year |
|---|---|
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Disopyra | 1980 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
[Oxprenolol in the treatment and prevention of cardiac arrhythmias].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature | 1975 |
Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Delayed-A | 1985 |
[Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Tri | 1985 |
Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Animals; Arrhythmias, Cardiac; Clinical Trials as Topic; D | 1985 |
Oxprenolol and ventricular ectopic activity of the heart.
Topics: Arrhythmias, Cardiac; Attitude to Health; Clinical Trials as Topic; Humans; Myocardial Infarction; O | 1974 |
26 other studies available for oxprenolol and Arrhythmia
| Article | Year |
|---|---|
[Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol].
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Disease Models, Animal; E | 1984 |
[The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol].
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Carteolol; Disease Models, Animal; | 1984 |
Studies with long acting propranolol.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Delayed-Action Preparations; Half-Life; Heart Rate; Humans; H | 1984 |
Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arrhythmias, Cardiac; Female; Heart Atria; Heart R | 1977 |
[Coparative pharmacological study of new adrenergic beta receptor blocking aromatic derivatives of oxybutanolamine and trasicor].
Topics: Adrenergic beta-Antagonists; Amino Alcohols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; | 1977 |
[beta-receptor blockaders in cardiac arrhythmias].
Topics: Adrenergic beta-Antagonists; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atenolol; Bradycardia; Electro | 1978 |
Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels | 1978 |
[Therapy of postoperative arrhythmias (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complex | 1979 |
Effect of beta receptor blockade on the initiation and perpetuation of ouabain-induced ventricular tachyarrhythmia.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Female; Heart Rate | 1975 |
[Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Drug Evaluation; Drug Synergism; Elec | 1979 |
Beta-blockade in subarachnoid haemorrhage.
Topics: Arrhythmias, Cardiac; Humans; Male; Middle Aged; Oxprenolol; Subarachnoid Hemorrhage | 1978 |
[beta Blocking agent treatment in hyperthyroidism in children].
Topics: Age Factors; Arrhythmias, Cardiac; Child; Child, Preschool; Female; Humans; Hyperthyroidism; Infant, | 1977 |
Electrophysiologic properties of intravenous oxprenolol in man.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Node; Female; Heart Conduction System; Humans; M | 1977 |
[Use of beta adrenergic receptor blockaders in the early postoperative period].
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Evaluation; Humans; Middle Aged; Oxprenolol; Pindolol; Posto | 1977 |
The R-R interval histogram.
Topics: Arrhythmias, Cardiac; Electrocardiography; Heart Rate; Humans; Male; Monitoring, Physiologic; Oxpren | 1976 |
[Trasicor in acute supraventricular arrhythmias].
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Female; Heart Ventricles; Humans; Male | 1975 |
[Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
Topics: Adult; Alprenolol; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Enflurane; Halothane | 1975 |
Circulatory collapse after oral oxprenolol.
Topics: Arrhythmias, Cardiac; Heart Ventricles; Humans; Isoproterenol; Male; Middle Aged; Oxprenolol; Shock | 1975 |
Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group.
Topics: Arrhythmias, Cardiac; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studie | 1990 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
[Clinical pharmacology of a new beta-adrenergic blocking agent--Trasicor].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Depression, Chemical; Drug Evaluation; Heart Rate | 1973 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Fail | 1973 |
[Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Arrhythmias, Cardiac; Evaluation S | 1972 |
[Use of trasycor in disorders of the cardiac rhythm and ischemic heart disease].
Topics: Administration, Oral; Arrhythmias, Cardiac; Coronary Disease; Humans; Oxprenolol | 1974 |
[Action of a beta-blocking agent, oxprenolol, in the treatment of rhythm disorders].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Child; Child, Preschool; Female; Humans; Infant; Infa | 1972 |
Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Humans; Middle Aged; Myocardial Infarction; Oxprenolol | 1971 |